BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

872 related articles for article (PubMed ID: 19068468)

  • 21. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
    Jordan K; Kasper C; Schmoll HJ
    Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting.
    Perez EA
    Cancer J Sci Am; 1998; 4(2):72-7. PubMed ID: 9532406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.
    Navari RM; Aapro M
    N Engl J Med; 2016 Apr; 374(14):1356-67. PubMed ID: 27050207
    [No Abstract]   [Full Text] [Related]  

  • 24. Practice Patterns for Prevention of Chemotherapy-Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real-World Prescribing Data.
    Aapro M; Scotté F; Escobar Y; Celio L; Berman R; Franceschetti A; Bell D; Jordan K
    Oncologist; 2021 Jun; 26(6):e1073-e1082. PubMed ID: 33555084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State of the Art Antiemetic Therapy for Cancer Patients.
    Lau TK; Yip CH; Yeo W
    Curr Oncol Rep; 2016 Jan; 18(1):2. PubMed ID: 26694923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemotherapy induced emesis: pathophysiology and prevention].
    Mailliez A; Bonneterre J
    Bull Cancer; 2010 Feb; 97(2):233-43. PubMed ID: 20051348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting].
    Durand JP; Madelaine I; Scotté F
    Bull Cancer; 2009 Oct; 96(10):951-60. PubMed ID: 19734117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting.
    Tan M
    Expert Opin Pharmacother; 2003 Sep; 4(9):1563-71. PubMed ID: 12943486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009.
    Jordan K; Roila F; Molassiotis A; Maranzano E; Clark-Snow RA; Feyer P;
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S37-42. PubMed ID: 20824481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydration requirements in patients receiving highly emetogenic chemotherapy.
    Erickson R; Nebughr N; Mosier MC; Nibley W
    Future Oncol; 2019 Mar; 15(7):753-761. PubMed ID: 30499739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential.
    Olver I; Clark-Snow RA; Ballatori E; Espersen BT; Bria E; Jordan K
    Support Care Cancer; 2011 Mar; 19 Suppl 1():S33-6. PubMed ID: 20803222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis.
    Perez EA
    J Clin Oncol; 1995 Apr; 13(4):1036-43. PubMed ID: 7707101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.
    Saito M; Aogi K; Sekine I; Yoshizawa H; Yanagita Y; Sakai H; Inoue K; Kitagawa C; Ogura T; Mitsuhashi S
    Lancet Oncol; 2009 Feb; 10(2):115-24. PubMed ID: 19135415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimens.
    Grunberg SM
    Blood Rev; 1989 Dec; 3(4):216-21. PubMed ID: 2692744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.
    Olver I; Ruhlmann CH; Jahn F; Schwartzberg L; Rapoport B; Rittenberg CN; Clark-Snow R
    Support Care Cancer; 2017 Jan; 25(1):297-301. PubMed ID: 27572335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of chemotherapy-induced nausea and vomiting.
    Tortorice PV; O'Connell MB
    Pharmacotherapy; 1990; 10(2):129-45. PubMed ID: 2190193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ESMO 2004. Nausea and vomiting caused by chemotherapy: improving the treatment].
    Longo F; Mansueto G
    Tumori; 2005; 91(1):suppl 36-48. PubMed ID: 15850022
    [No Abstract]   [Full Text] [Related]  

  • 38. Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting: results of a meta-analysis of randomized controlled trials.
    del Giglio A; Soares HP; Caparroz C; Castro PC
    Cancer; 2000 Dec; 89(11):2301-8. PubMed ID: 11147601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients.
    Shankar A; Roy S; Malik A; Julka PK; Rath GK
    Asian Pac J Cancer Prev; 2015; 16(15):6207-13. PubMed ID: 26434818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Antiemetic Therapy for Hepatic Transcatheter Arterial Infusion Chemotherapy with Cisplatin.
    Hashizume J; Higuchi N; Sato K; Kodama Y; Matsunaga N; Sakamoto T; Yamaguchi K; Nakamura T; Kitahara T; Sasaki H
    Biol Pharm Bull; 2016; 39(4):611-4. PubMed ID: 27040634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.